Uterine Morphology in Normogonadotropic Anovulation: PCOS vs HPOD

Overview

This study compared uterine and endometrial ultrasound measurements among women with normogonadotropic anovulation due to PCOS or HPOD and healthy controls. Significant reductions in uterine and endometrial dimensions were observed in anovulatory women, with distinct differences between PCOS and HPOD groups influenced by hormonal and metabolic factors.

Background

Ultrasonographic evaluation of uterine morphology is essential for assessing reproductive health and diagnosing menstrual irregularities. Normogonadotropic anovulation, including PCOS and HPOD, affects uterine and endometrial structure, but data comparing these conditions are limited. Hormonal imbalances and metabolic disturbances in PCOS and HPOD may alter uterine size and endometrial thickness, impacting fertility and clinical outcomes. Understanding these morphological differences can guide diagnosis and management in affected women.

Data Highlights

Key Findings

• Women with normogonadotropic anovulation exhibit significantly reduced uterine and endometrial measurements compared to healthy controls (p ≤0.001).
• PCOS patients have significantly smaller uterine length, height, and volume than those with HPOD.
• Endometrial thickness is increased in PCOS women with hyperandrogenemia.
• Myometrial measurements negatively correlate with AMH and FSH levels, and positively with estradiol and prolactin.
• Endometrial measurements negatively correlate with AMH and FSH, and positively with estradiol, prolactin, 17-hydroxyprogesterone, fasting insulin, and insulin resistance.

Clinical Implications

Uterine and endometrial morphology in normogonadotropic anovulation reflects the combined effects of reproductive hormones and metabolic status, emphasizing the need for comprehensive hormonal and metabolic evaluation in these patients. Ultrasonographic assessment can aid in differentiating PCOS from HPOD and guide individualized management strategies targeting hormonal and metabolic abnormalities to improve reproductive outcomes.

Conclusion

Uterine morphology differs significantly between women with PCOS and HPOD and is influenced by hormonal and metabolic factors. These findings underscore the importance of integrating ultrasonographic evaluation with clinical and biochemical assessments in managing normogonadotropic anovulation.

References

1. Clinical Department of Gynecological Endocrinology and Gynecological Oncology, University Hospital Krakow, 2024 -- Uterine Structure in Normogonadotropic Anovulation